Clinical Trial Update: COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma [Phase 3]

View source ↗

Summary

This entry reports on a Phase 3 trial evaluating a COX-2 inhibitor with concurrent chemoradiation for locally advanced head and neck cancer, with status current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• COX-2 inhibitor (COX-2 inhibitor)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Head and Neck Cancer | Phase 3 | Status: UNKNOWN